Skip to content

Science Not yet confirmed elsewhere1 publisher 3 min read Published

A 343-base-pair switch for tendon, and the bone ridge that proves it works

An international team maps a Scleraxis enhancer conserved from coelacanths to humans. Delete its 343 bp core and the mouse limb loses a bone ridge, not a tendon.

The Scientist · Science desk

Send a correction

What happened

  • Transgenic reporter mice let the team pin down a 5.3 kb enhancer downstream of Scleraxis that reproduced the gene's expression pattern faithfully.
  • Inside it sits a 343 bp element conserved from lobe-finned fishes to tetrapods, enough on its own to drive Scx expression in the developing limb.
  • Mice with that 343 bp element deleted lost most endogenous Scx expression in the limb and never formed the deltoid tuberosity.
  • Shukunami frames the work as groundwork for tissues that repair badly because they carry no blood supply.

Why it matters

  • What's now possible capability A short element that fires only in tendon, ligament and enthesis is a candidate address line for restricting a payload or a label to those tissues, which broad promoters cannot do.
  • What it limits constraint Because expression rebounds, deleting this core does not give a clean loss-of-function animal; anyone using it as a model is working with a partial, time-limited knockdown.
  • Who has to decide decision Tool builders now have to pick between the 5.3 kb region and its core, and the two do different jobs: one sets the timing, the rest sustain the level.
  • What it sets up precedent The scoreable phenotype was skeletal, so enthesis-directed interventions are likely to be judged on bone morphology rather than on tendon mechanics.

An enhancer is a piece of DNA that decides when and where a gene switches on [2]. The arithmetic worth noticing here is how little of the region does the early work: the conserved core is 343 base pairs sitting inside a 5.3 kb block, roughly 6 percent of the sequence the team began with [15], and that core on its own reproduced Scx expression in the developing limb [4].

Take the core out and the limb loses most of its endogenous Scx expression early, then gets it back later; the team attributes the recovery to other elements inside the same 5.3 kb region [5][7]. That is redundancy, and it is the most useful thing in the paper for anyone who wants to build with this sequence. The region separates into at least two functional jobs, one that sets the start time and something else that holds the level.

What did not come back was the deltoid tuberosity, the ridge on the humerus where the deltoid muscle attaches [5][6]. So the lasting casualty of deleting a tendon-and-ligament enhancer was a piece of bone. That is the enthesis relationship in physical form: the attachment program on the soft-tissue side shapes the skeleton it pulls against. It also sets the assay. Work aimed at entheses will be scored by looking at bone, which is convenient, because bone is easy to image and tendon mechanics are not.

On regeneration, keep the claim narrow. Shukunami's own stated reason these tissues repair so poorly is that they are avascular [9], and a 343 bp switch does not add blood supply. Nothing in this study repaired anything; the readouts are reporter mice and a genome-edited deletion in embryos [3][11].

What the element plausibly offers is an address rather than a treatment. Scx is already reactivated in adults during repair and during adaptation to mechanical loading [8], so the gene is live in exactly the tissue anyone would want to influence. The missing part has been a way to act only there. A short conserved element that fires in tendon, ligament and enthesis, and that Shukunami describes as conserved from coelacanths to humans [10], is the kind of component reporter lines and tissue-restricted delivery are assembled from. Whether the human orthologue behaves the same way is not something this paper tested.

The conservation itself is the strongest signal in the work. A 343 bp stretch that survives from lobe-finned fishes to tetrapods [4] has been under selection for a very long time, which is a reasonable proxy for it doing something that cannot be lost. And Scx loss-of-function is already known to break tendon, ligament and enthesis development [13], so the enhancer sits upstream of a phenotype with a documented cost. The team says its next objective is the wider regulatory network above Scx [14], which is the honest description of where this stands: one switch mapped, the wiring behind it not.

What to watch

  • Whether the human orthologue of the 343 bp CSE drives the same tendon-restricted activity, which the mouse work does not establish.
  • Whether the other dSE elements that restore Scx expression get mapped, splitting the region into a timing part and a maintenance part.
  • Whether CSE activity shows up in adult injury or mechanical-loading models rather than only in embryonic limbs.

Clarity's read

What the record supports and how the coverage leans. The claims behind it follow.

Reality

Evidence58
Adoption
Not scored
Hype gap+22
Incentives62
Confidence42
Why these scores

Claim ledger

Ranked by verification strength, evidence, and original report placement.

  1. [1]

    An international research team identified a novel enhancer that controls tissue-specific expression of Scleraxis (Scx), a transcription factor for formation and maturation of tendons, ligaments and entheses; the work was published in the journal Development.

    Reported SupportedView cited source
  2. [2]

    Enhancers are DNA sequences that function as genetic switches, controlling when and where genes are activated.

    Reported SupportedView cited source
  3. [3]

    Using transgenic reporter mice, the team identified a 5.3 kb downstream Scleraxis enhancer (dSE) that drove robust, stable and faithful reporter activity.

    Reported SupportedView cited source

Get this ledger inside ChatGPT. Ask about any of our stories and the answer brings its figure, each claim’s verdict and the sources. Free, no account.

Add to ChatGPTAdd to Claude

Sources

1 independent publisher whose own reporting we read for this story.

  1. phys.org

    1 article · August 26, 2026

    Team identifies an evolutionarily conserved enhancer that regulates tendon and ligament development

Share your take

Let Clarity write the post for you.

Signed-in readers get a short post drafted on this story in the register they choose — narrative, analytical, or a direct position — editable to the last word before it goes anywhere. The share buttons at the top of this story work without an account.

Topics and entities

Follow any of these and your For You feed starts watching them — no settings page required.

Topics

Entities

Loading related stories